We are monitoring the impact of COVID-19 on Europe Viral Inactivation Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3100
Share on
Share on

Europe Viral Inactivation Market Research Report - Segmented By Method, By Product, By Application, By End User & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2019-2024

Pulished: February, 2020
ID: 3100
Pages: 140

Europe Viral Inactivation Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Viral Inactivation Market is valued at USD 120.66 million in 2019 and estimated to be growing at a CAGR of 12.1%, to reach USD 213.60 million by 2024 during the forecast period 2019-2024.

Viral Inactivation is the method by which viral cells are killed or made inactive. It is done in order to enhance safety and to prevent contamination of products by viruses. If the viruses are present in the final product, they are in an inactive form. All the inactivation techniques are done primarily in blood plasma and food industries to protect the products from viruses.

Among the many methods in which Viral Inactivation is done, some of them are, irradiation by UV rays, dry heating, pasteurization, solvent/detergent usage and lowering the pH among others. Pasteurization is useful only if the proteins to be protected have more thermal resistance than the viruses to be killed. UV radiations achieve the ends by creating nucleic acid dimers, thus affecting the life cycle and reproduction processes of viruses. Viral Inactivation by solvents and detergents is the most commonly used method in the blood plasma industry, but it is effective only for viruses encapsulated in lipid molecules. The detergents/solvents interact with the lipid layers in which viruses are present and make them ineffective since they cannot survive without lipid molecules. Lowering pH is effective when the molecules in the product are more resistant than viruses.

The driving factors of Europe Viral Inactivation market are the focus of research and development industries in life sciences, high growth in pharmaceuticals and biotechnology industries, the launch of new drugs, rising incidence of chronic diseases and growing support of the government in biotechnology and pharmaceuticals sectors among others. However, this market is constrained by the presence of strong consolidation and fewer skilled workers.

This research report segmented and sub-segmented into the following categories:

  • By Method: Solvent/Detergent Method, Pasteurisation, UV Radiation, Microwave Heating, and High-Energy Light
  • By Product: Services, Kits and Reagents, Accessories and Viral Inactivation Systems
  • By Application: Vaccines and Therapeutics, Stem Cell Products, Cell Culture, Gene Therapy, Blood & Blood Products
  • By End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, and Others
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe is the second-largest market in the world by share. Factors such as rising support of the government in pharmaceuticals and biotechnology sectors and rising incidence of chronic diseases are expected to drive the growth of this market in the forecast period.

Key players operating in the Europe Viral Inactivation Market profiled in this report are Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc.,

1.Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Method                       

        5.1.1 Solvent/Detergent Method            

        5.1.2 Pasteurization       

        5.1.3 UV Radiation          

        5.1.4 Microwave Heating             

        5.1.5 High-Energy Light 

        5.1.6  Y-o-Y Growth Analysis, By Method              

        5.1.7  Market Attractiveness Analysis, By Method            

        5.1.8  Market Share Analysis, By Method             

                5.2 Product

        5.2.1 Kits and Reagents

        5.2.2 Services    

        5.2.3 Accesories               

        5.2.4 Viral Inactivation Systems 

        5.2.5 Y-o-Y Growth Analysis, By Product               

        5.2.6 Market Attractiveness Analysis, By Product             

        5.2.7 Market Share Analysis, By Product               

                5.3 Application                 

        5.3.1 Vaccines and Therapeutics               

        5.3.2 Stem Cell Products              

        5.3.3 Cell Culture             

        5.3.4 Gene Therapy       

        5.3.5 Blood & Blood Products     

        5.3.6 Y-o-Y Growth Analysis, By Application         

        5.3.7  Market Attractiveness Analysis, By Application      

        5.3.8 Market Share Analysis, By Application        

                5.4 End User                      

        5.4.1 Pharmaceutical and Biotechnology Companies       

        5.4.2 Contract Research Organizations   

        5.4.3 Academic Research Institutes         

        5.4.4 Other End Users   

        5.4.5 Y-o-Y Growth Analysis, By End User             

        5.4.6  Market Attractiveness Analysis, By End User          

        5.4.7 Market Share Analysis, By End User             

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Method

                        6.1.3.2 By Product

                        6.1.3.3 By Application

                        6.1.3.4 By End User

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Method

                        6.1.4.2 By Product

                        6.1.4.3 By Application

                        6.1.4.4 By End User

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Method

                        6.1.5.2 By Product

                        6.1.5.3 By Application

                        6.1.5.4 By End User

                6.2 U.K                 

                6.3 Spain     

                6.4 Germany                     

                6.5 Italy       

                6.6 France  

7.Strategic Analysis                

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                 

                8.1 Clean Cells                  

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Charles River Laboratories International Inc.                

                8.3 Danaher Corporation     

                8.4 Merck KGaA       

                8.5 Parker Hannifin 

                8.6 Red Source Technologies                     

                8.7 Sartorius AG       

                8.8 SGS S.A

                8.9 Texcell Inc                   

                8.10 Viral Inactivated Plasma Systems SA     

                8.11 WuXi Pharma Tech Inc.                       

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables                

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Viral Inactivation Market By Method, From 2019-2024 ( USD Million )
  2. Europe Solvent/Detergent method Market By Region, From 2019-2024 ( USD Million )
  3. Europe Pasteurization Market By Region, From 2019-2024 ( USD Million )
  4. Europe UV Radiation Market By Region, From 2019-2024 ( USD Million )
  5. Europe Microwave Heating Market By Region, From 2019-2024 ( USD Million )
  6. Europe High-Energy Light Market By Region, From 2019-2024 ( USD Million )
  7. Europe Viral Inactivation Market By Products, From 2019-2024 ( USD Million )
  8. Europe Services Market By Region, From 2019-2024 ( USD Million )
  9. Europe Kits and Reagents Market By Region, From 2019-2024 ( USD Million )
  10. Europe Accessories Market By Region, From 2019-2024 ( USD Million )
  11. Europe Viral Inactivation Systems Market By Region, From 2019-2024 ( USD Million )
  12. Europe Viral Inactivation Market By Application, From 2019-2024 ( USD Million )
  13. Europe Vaccines and Therapeutics Market By Region, From 2019-2024 ( USD Million )
  14. Europe Stem Cell Products Market By Region, From 2019-2024 ( USD Million )
  15. Europe Cell Culture Market By Region, From 2019-2024 ( USD Million )
  16. Europe Gene Therapy Market By Region, From 2019-2024 ( USD Million )
  17. Europe Blood & Blood Products Market By Region, From 2019-2024 ( USD Million )
  18. U.K. Viral Inactivation Market By Method, From 2019-2024 ( USD Million )
  19. U.K. Viral Inactivation Market By Products, From 2019-2024 ( USD Million )
  20. U.K. Viral Inactivation Market By Application, From 2019-2024 ( USD Million )
  21. Germany Viral Inactivation Market By Method, From 2019-2024 ( USD Million )
  22. Germany Viral Inactivation Market By Products, From 2019-2024 ( USD Million )
  23. Germany Viral Inactivation Market By Application, From 2019-2024 ( USD Million )
  24. France Viral Inactivation Market By Method, From 2019-2024 ( USD Million )
  25. France Viral Inactivation Market By Products, From 2019-2024 ( USD Million )
  26. France Viral Inactivation Market By Application, From 2019-2024 ( USD Million )
  27. Italy Viral Inactivation Market By Method, From 2019-2024 ( USD Million )
  28. Italy Viral Inactivation Market By Products, From 2019-2024 ( USD Million )
  29. Italy Viral Inactivation Market By Application, From 2019-2024 ( USD Million )
  30. Spain Viral Inactivation Market By Method, From 2019-2024 ( USD Million )
  31. Spain Viral Inactivation Market By Products, From 2019-2024 ( USD Million )
  32. Spain Viral Inactivation Market By Application, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample